Rockefeller Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Rockefeller Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,030	Closed	-$301K	–	2554
2019 Q4	$301K	Hold	5,030	–	–	﹤0.01%	678
2019 Q3	$141K	Hold	5,030	–	–	﹤0.01%	701
2019 Q2	$190K	Hold	5,030	–	–	﹤0.01%	584
2019 Q1	$196K	Hold	5,030	–	–	﹤0.01%	606
2018 Q4	$107K	Buy	+5,030	New	+$130K	﹤0.01%	453

Rockefeller Capital Management's BOLD Position: Q1 2020 in Review

Rockefeller Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 5,030 shares — an estimated $301K sold.

Rockefeller Capital Management first reported a position in BOLD in Q4 2018 and held it in 5 quarters. The position peaked at $301K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Rockefeller Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Rockefeller Capital Management sold 5,030 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $301K.
Rockefeller Capital Management first reported a position in Audentes Therapeutics, Inc in Q4 2018 and held it in 5 quarters.
Rockefeller Capital Management's Audentes Therapeutics, Inc position peaked at $301K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Rockefeller Capital Management's 13F filing for Q1 2020, filed 12 May 2020.